Aliskiren

Chemical formula: C₃₀H₅₃N₃O₆  Molecular mass: 551.758 g/mol  PubChem compound: 5493444

Therapeutic indications

Aliskiren is indicated for:

Essential hypertension

Population group: only adults (18 years old or older)

Essential hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Aliskiren is contraindicated in the following cases:

Hereditary or idiopathic angioedema

at least one of
Idiopathic angio-oedema
Hereditary angioneurotic edema

Pregnancy

Pregnancy

Breast-feeding

Lactation

ACEI or ARB in patients with diabetes mellitus or renal impairment

at least one of
ACE inhibitors, plain
Angiotensin II antagonists, plain and additionally at least one of
Diabetes mellitus



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

History of angioedema with aliskiren

Angioedema

P-gp potent inhibitors

P-glycoprotein inhibitors

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2021: TEKTURNA Film-coated tablet
Summary of Product Characteristics (SPC) 2023: RASILEZ Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈